Shareholder of issuer (GRMN) files Form 144 to sell 10431 shares of common stock
Rhea-AI Filing Summary
Form 144 discloses that a holder plans to sell 10431 shares of common stock through UBS Financial Services, Inc. on or about 12/16/2025 on the NYSE, with an aggregate market value of 2151757.79.
The shares were acquired from the issuer on 12/15/2025 through vesting of restricted stock units in the same amount of 10431. By signing, the person represents that they do not know any material adverse information about the issuer that has not been publicly disclosed.
Positive
- None.
Negative
- None.
FAQ
What does this Form 144 filing for GRMN disclose?
This Form 144 reports that a holder plans to sell 10431 shares of common stock through UBS Financial Services, Inc. on or about 12/16/2025 on the NYSE, with an aggregate market value of 2151757.79.
How many GRMN shares are planned to be sold and what is their market value?
The filing shows a planned sale of 10431 common shares with an aggregate market value of 2151757.79.
How were the GRMN shares in this Form 144 acquired?
The shares were acquired on 12/15/2025 through the vesting of restricted stock units from the issuer, in the amount of 10431 shares.
Which broker and exchange are involved in this GRMN share sale?
The proposed sale will be executed through UBS Financial Services, Inc. and the shares are to be sold on the NYSE.
What representations does the seller make in this GRMN Form 144 notice?
By signing the notice, the person represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
When were the restricted stock units related to this GRMN sale vested and paid?
The common shares were acquired on 12/15/2025 via vesting of restricted stock units, with the date of payment also 12/15/2025 and the nature of payment listed as N/A.